Chemoinformaics analysis of Phragmalin 3-isobutyrate 30-propionate
| Molecular Weight | 686.751 | nRot | 7 |
| Heavy Atom Molecular Weight | 640.383 | nRig | 0 |
| Exact Molecular Weight | 686.294 | nRing | 8 |
| Solubility: LogS | -6.935 | nHRing | 4 |
| Solubility: LogP | 7.417 | No. of Aliphatic Rings | 7 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 95 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 49 | No. of Aromatic Carbocycles | 0 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 4 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 36 | No. of Saturated Rings | 7 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 5 |
| nHA | 13 | APOL | 101.218 |
| nHD | 1 | BPOL | 63.5075 |
| QED | 0.401 |
| Synth | 2.331 |
| Natural Product Likeliness | 0.957 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.016 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.463 |
| MDCK | 0.00000908 |
| BBB | 0.292 |
| PPB | 0.980382 |
| VDSS | 3.1 |
| FU | 0.0226621 |
| CYP1A2-inh | 0.368 |
| CYP1A2-sub | 0.206 |
| CYP2c19-inh | 0.434 |
| CYP2c19-sub | 0.618 |
| CYP2c9-inh | 0.327 |
| CYP2c9-sub | 0.958 |
| CYP2d6-inh | 0.045 |
| CYP2d6-sub | 0.037 |
| CYP3a4-inh | 0.158 |
| CYP3a4-sub | 0.104 |
| CL | 5.924 |
| T12 | 0.072 |
| hERG | 0.07 |
| Ames | 0.005 |
| ROA | 0.027 |
| SkinSen | 0.923 |
| Carcinogencity | 0.04 |
| EI | 0.961 |
| Respiratory | 0.283 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.900405 |